OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer

Ann Oncol. 2019 Oct 1;30(10):1673. doi: 10.1093/annonc/mdz171.

Authors

T Y Seiwert, C C Foster, E A Blair, T G Karrison, N Agrawal, J M Melotek, L Portugal, R J Brisson, A Dekker, S Kochanny, Z Gooi, M W Lingen, V M Villaflor, D T Ginat, D J Haraf, E E Vokes

PMID: 31168601
DOI: 10.1093/annonc/mdz171

No abstract available

Publication types

Published Erratum